Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer resolves 200 Trasylol lawsuits
Fierce Pharma
Tuesday, September 14, 2010 - 11:40am
tags:
Bayer, lawsuits, settlements, Trasylol
K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval
NASDAQ.com
Tuesday, September 14, 2010 - 10:32am
tags:
KV Pharmaceutical, FDA
Cell Therapeutics to appeal FDA pixantrone decision
Bizjournals.com
Tuesday, September 14, 2010 - 10:21am
tags:
pixantrone, Cell Therapeutics, non-Hodgkin's lymphoma
Do rich markets lure biotechs away from low-cost remedies?
Fierce Biotech Research
Tuesday, September 14, 2010 - 10:19am
tags:
biotech, India, Brazil, China, South Africa
Arena's Lorcaserin: Therapeutic Value Zero?
Seeking Alpha
Tuesday, September 14, 2010 - 10:15am
tags:
Arena Pharmaceuticals, lorcaserin, obesity
BCA’s Brenner: Avastin And FDA Approval Standards
Pharmalot
Tuesday, September 14, 2010 - 10:14am
tags:
Avastin, FDA, breast cancer, Roche, Genentech
Is Celldex Therapeutics on the Rebound?
Seeking Alpha
Tuesday, September 14, 2010 - 10:02am
tags:
Celldex
Amgen Plans to Sell $1.5 Billion of Bonds in Second Debt Offering of 2010
Bloomberg
Tuesday, September 14, 2010 - 8:07am
tags:
Amgen, bonds
Ironwood, Forest boast positive IBS drug trial
Yahoo/AP
Tuesday, September 14, 2010 - 8:06am
tags:
IBS, irritable bowel syndrome, Ironwood, Forest Labs, linaclotide
Acura Pharmaceuticals Sued by Shareholder After FDA Rejects Painkiller
Bloomberg
Tuesday, September 14, 2010 - 8:03am
tags:
FDA, Acura Pharmaceuticals, shareholders, Acurox, painkillers
Bone Drug May Cause Fractures
WSJ Online
Tuesday, September 14, 2010 - 8:02am
tags:
osteoporosis, fractures, biophosphonates, Actonel, Sanofi, Boniva, Roche, GSK, Merck, Fosamax, Warner Chilcott
Forest Laboratories responds to FDA Daxas request
Yahoo/AP
Monday, September 13, 2010 - 8:25pm
tags:
FDA, Daxas
What Arena Investors Should Worry About
Forbes
Monday, September 13, 2010 - 8:22pm
tags:
Arena Pharmaceuticals, obesity, FDA
What's the Margin Trend at Endo Pharmaceuticals Holdings?
Motley Fool
Monday, September 13, 2010 - 8:21pm
tags:
Endo, Merck, JNJ, Eli Lilly, Abbott Laboratories
Does Botox Prevent Migraines or Is It Just Acupuncture?
BNET Pharma
Monday, September 13, 2010 - 4:03pm
tags:
migraines, placebo effect, Allergan, Botox
Did Dendreon Open Doors For Opexa Partnerships?
Yahoo/IndieResearch
Monday, September 13, 2010 - 4:02pm
tags:
Opexa, Dendreon, stem cells, Novartis
Incyte to begin study on blood cancer drug
Yahoo/AP
Monday, September 13, 2010 - 4:00pm
tags:
Incyte, blood cancer, FDA
Dr. Reddy's shares rise on Morgan Stanley upgrade
Yahoo/AP
Monday, September 13, 2010 - 3:59pm
tags:
Dr Reddy's, upgrades
Novartis's Experimental Meningitis Vaccine Meets Goals in Late-Stage Study
Bloomberg
Monday, September 13, 2010 - 12:54pm
tags:
meningitis, vaccines, Novartis
Xenoport rallies on drug update; indexes gain
Marketwatch
Monday, September 13, 2010 - 12:53pm
tags:
XenoPort, arbaclofen placarbil, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.